04:38 PM EDT, 09/25/2025 (MT Newswires) -- Christopher Causey, Director, on September 24, 2025, sold 1,000 shares in United Therapeutics ( UTHR ) for $440,000. Following the Form 4 filing with the SEC, Causey has control over a total of 4,865 common shares of the company, with 4,865 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1082554/000123733425000004/xslF345X05/primarydocument.xml